GI Effects Maldigestion Score Test · Stool

When digestion fails quietly, the symptoms can be vague: bloating after meals, oily or foul-smelling stools, gradual weight loss, or fatigue that no diet seems to fix. The cause is often that your pancreas, gut enzymes, or bile flow are not breaking food into pieces small enough to absorb. The Maldigestion Score is one of the few tools that tries to put a number on this process by combining several stool markers into a single readout.

This is a research-grade composite score, not a textbook clinical test. Standardized cutpoints and outcome data tied to the score itself are limited, so a single result is best understood as a starting point that points you toward more specific testing rather than a final answer.

What the Score Captures

The score pulls together stool measurements that reflect different stages of digestion. The most informative ingredient is pancreatic elastase-1, an enzyme made by your pancreas that survives the trip through your gut and shows up in stool. Low elastase points toward pancreatic exocrine insufficiency, or PEI (a state where your pancreas does not release enough digestive enzymes). The score also incorporates fecal fat fractions and putrefactive short-chain fatty acids, which are the chemical leftovers your gut bacteria produce when undigested protein arrives in the colon.

Higher numbers on the composite suggest more maldigestion. Lower numbers suggest your enzymes, bile, and absorption surface are doing their jobs. Because the score is a composite, the more useful information often lies in which component is driving the change, not the headline number.

Why Maldigestion Matters

When your digestive system cannot break down food properly, the consequences cascade. Fat-soluble vitamins (A, D, E, K) get poorly absorbed. Calorie intake silently drops, leading to weight loss and muscle wasting. The condition most clearly tied to this picture is pancreatic exocrine insufficiency. Guideline reviews describe PEI as a meaningful driver of malabsorption symptoms, increased morbidity, and reduced quality of life when left unrecognized.

PEI is not just a problem of chronic pancreatitis. It also shows up after pancreatic surgery, in cystic fibrosis, in advanced pancreatic cancer, after esophagectomy, in a meaningful share of people with type 1 diabetes, and even in people living with HIV on effective antiretroviral therapy. The pancreas also loses function gradually with age, which can push some older adults into clinically meaningful enzyme insufficiency without an obvious trigger.

Conditions Linked to Poor Digestion

The conditions most often associated with abnormal results cluster into a few groups. Each tells a slightly different story about why digestion is failing.

• Pancreatic causes: chronic pancreatitis, prior pancreatic surgery, advanced pancreatic cancer, and age-related pancreatic decline all reduce enzyme output.
• Cystic fibrosis: thick secretions block pancreatic ducts and cause near-universal enzyme insufficiency requiring lifelong replacement.
• Post-surgical states: esophagectomy and pancreatoduodenectomy disrupt the timing and mixing of food with enzymes.
• Metabolic conditions: type 1 diabetes is associated with exocrine pancreas dysfunction, and HIV on stable therapy can also coexist with PEI.

Reference Ranges

Standardized clinical cutpoints for the composite score itself have not been published in peer-reviewed literature. The score is a proprietary index, and the most rigorous reference data exists for individual components, particularly pancreatic elastase-1, which has been validated as a screening tool for PEI in a meta-analysis. Treat any number on the report as orientation, not a verdict, and pay attention to which components are driving the result.

Compare your results within the same lab over time for the most meaningful trend, since assay methods and reference cutoffs vary between providers.

Tracking Your Trend

A single stool reading can be noisy. Recent meals, transit time, and sample handling all shift the numbers, and individual components like fecal fat have wide day-to-day variability. The trajectory matters more than any one snapshot. If you are starting an enzyme replacement, changing your diet, or recovering from an acute event, retest in 3 to 6 months to see whether the trend is moving in the right direction. After that, at least annual monitoring is reasonable for anyone with ongoing risk factors.

When Results Can Be Misleading

• Recent dietary extremes: an unusually high-fat or very low-fat diet in the days before sample collection can shift fat-related components without reflecting your typical digestion.
• Acute gut illness: diarrhea or a recent infection alters transit time and stool composition enough to make a single reading unrepresentative.
• Sample handling: stool that sits at room temperature too long, or is collected during an episode of watery diarrhea, can produce results that do not reflect baseline.
• Medications affecting motility: drugs that speed up or slow down the gut can shift stool composition without indicating a true digestion problem.

What to Do If Your Score Is Elevated

An abnormal Maldigestion Score is a prompt for a more specific workup, not a diagnosis. The most useful next step is to look at the elastase-1 value directly, since it has stronger validation than the composite. If elastase is low and fat markers are elevated, that combination points toward pancreatic exocrine insufficiency and warrants a conversation with a gastroenterologist about confirmatory testing and pancreatic enzyme replacement therapy. If elastase is normal but fat markers are high, consider bile acid issues, small bowel disease, or absorption problems further down the GI tract. Pairing this score with a celiac screen, fecal calprotectin, and a basic nutritional panel (vitamin D, B12, ferritin) gives you a clearer picture of whether maldigestion is translating into nutrient gaps.